Chapter title |
In Silico Models for Repeated-Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs.
|
---|---|
Chapter number | 9 |
Book title |
In Silico Methods for Predicting Drug Toxicity
|
Published in |
Methods in molecular biology, January 2016
|
DOI | 10.1007/978-1-4939-3609-0_9 |
Pubmed ID | |
Book ISBNs |
978-1-4939-3607-6, 978-1-4939-3609-0
|
Authors |
Fabiola Pizzo, Emilio Benfenati |
Editors |
Emilio Benfenati |
Abstract |
The preclinical stage in drug development requires the determination of repeated-dose toxicity (RDT) in animal models. The main outcome of RDT studies is the determination of the no observed adverse effect level (NOAEL) and the lowest observed adverse effect level (LOAEL). NOAEL is important since it serves to calculate the maximum recommended starting dose (MRSD) which is the safe starting dose for clinical studies in human beings. Since in vivo RDT studies are expensive and time-consuming, in silico approaches could offer a valuable alternative. However, NOAEL and LOAEL modeling suffer some limitations since they do not refer to a single end point but to several different effects and the doses used in experimental studies strongly influence the final results. Few attempts to model NOAEL and LOAEL have been reported. The available database and models for the prediction of NOAEL and LOAEL are reviewed here. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 15 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 27% |
Student > Ph. D. Student | 3 | 20% |
Student > Bachelor | 2 | 13% |
Lecturer | 1 | 7% |
Student > Doctoral Student | 1 | 7% |
Other | 1 | 7% |
Unknown | 3 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 20% |
Biochemistry, Genetics and Molecular Biology | 3 | 20% |
Environmental Science | 1 | 7% |
Mathematics | 1 | 7% |
Medicine and Dentistry | 1 | 7% |
Other | 1 | 7% |
Unknown | 5 | 33% |